Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Levels in Cochlear Perilymph
NCT03248856Phase 1Completed
- Start
- Oct 2017
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of triamcinolone acetonide in sensorineural hearing loss (SNHL) (4 arms). Primary endpoint: Triamcinolone levels in comparison at 2 years. Started Oct 2017; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on NCT03248856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03248856.